DESIGNING YOUR ENVIRONMENTAL MONITORING PROGRAM FOR MOLD. Presented by Aaron Bisceglia

Similar documents
Overview of a sterility assurance program for PET drugs

Bioburden Contamination Control: A Holistic Overview

FDA s Guidance for Industry

MICROBIOLOGICAL TOOLS FOR QUALITY ASSURANCE IN HATCHERY: Laboratory Methods

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Media Fill A Process Simution. Presented By Shikha Chauhan

USP <1116> and Contamination

Microbiology 101 Nina G. Parkinson NGP Consulting November 11, 2014

Environmental Monitoring of Aseptic Processing Areas - 1

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

Aseptic Process Validation

ANALYSIS OF FUNGI (MOLD) IN THE INDOOR ENVIRONMENTS BY DIRECT MICROSCOPIC EXAMINATION. (Analysis Code: FDE)

Study disproves misconception about contamination of sterile IPA bottles.

Disinfectant Qualification A Multifaceted Study

AIR AND SURFACE SAMPLING MEASUREMENTS OF FUNGAL CONTAMINANTS IN INDOOR ENVIRONMENTS

Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS

Microbiology Research Associates

MINIMUM REQUIREMENTS FOR A VENDOR

Microbiological Consideration for Non-Sterile Pharmaceutical

Mold Contaminations-Prevention, Investigation, Remediation and Risk Assessment Durham, NC September 17 th & 18 th, 2018

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

Technical Report No. 70 Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

PMF NEWSLETTER. Letter from the Editor. Pharmaceutical Microbiology Forum (PMF) 2011 Editorial Board. Volume 17, Number 3 March, 2011

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

PHCT 401 Aseptic Processes & Techniques

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

Analytical Service Code

Providing clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting

Indoor Air Quality Report

A risk based approach to managing environmental excursions

Exercise 19. Fungi: Molds and Yeasts F10 Or The Rotten World Around Us

Let s Talk Yeasts and Molds

A MICROBIAL RESISTANCE EVALUATION OF INDOOR MATERIALS AIR KRETE INSULATION SAMPLE. prepared for AIR KRETE

The Parenteral Drug Association

FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING

INTRODUCTION: METHODOLOGY: November 11, Mr. Tim Squier 487 Deerfield Dakota Dunes, SD 57049

MICROBES are microorganisms that are ever present

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Study Title Antibacterial Efficacy of Bio-Care Technology's Non-Porous Test Substance

Microbiological Quality: Understanding Drinking Water Quality and Management

Protocol Reference: Verification Protocol

MOLD REMEDIATION PROCEDURES AT A NEW JERSEY ELEMENTARY SCHOOL

sterility assurance Prove the power and your processes

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Identify principles for maintaining a "working" stock culture.

Compounding Pharmacies and the USP <71> Sterility Tests

MODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

Validation Guide for and

á61ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS

Tests to Support Sterility Claim. Imtiaz Ahmed

HardyVal TM CSP RANDOM TEST KIT

Efficacy Report Summarization for SoClean 2

Table of Contents. C. Recommended Remediation Firms: upon request

Porton Biopharma Limited 1/17/17

Current Industry Trends -Including Cleaning and Disinfection trends, Disinfectant Validation Trends, and Current Warning Letter Activity.

BREAD CONTAMINATION WITH FUNGUS

Extending the Life of Polymer Quenchants: Cause and Effect of Microbiological Issues

High-temperature drying of organically grown bread rye

TRYPTIC SOY AGAR (TSA) WITH LECITHIN AND TWEEN 80

Orthophenylphenol in healthcare environments: a trial related to a new administration method and a review of the literature*

for IND and RDRC Regulated PET Compounding

Whitepaper. High temperature HEPA filtration. Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Preview

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Introduction, by Tortora, Funke and Case, 11th Ed. TENTATIVE LECTURE OUTLINE DATE TOPIC CHAPTER

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Full Contact Details:

Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen

USP <797> Compliance Common Challenges and Potential Solutions

The Most Probable Number Method and Its Use in QC Microbiology

Cleaning Validation What do you need to consider to ensure a successful outcome?

RESIDENTIAL MOLD ASSESSMENT. Final Report. Your Address Here

When Quality Matters. Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing. Celebrating Over 50 Years In Business!

Residue removal in Cleanroom Environments

Aseptic Techniques. A. Objectives. B. Before coming to lab

Aseptic Processing Current Issues & Trends

Premise Microbial Testing

Air Quality Monitoring of Operation Theaters in Government Medical College and Hospital, Aurangabad, India

Preservation Efficacy Testing

HOW DO YOU TALK ABOUT MOLD WITHOUT SAYING THE M WORD IMG = A NEW NAME FOR AN OLD PROBLEM. Mold Growth!

MOLD FAQs. Frequently Asked Questions About Mold By Dr. Nathan Yost, MD. Building Sciences Corporation

MICROBIAL MEASUREMENTS AT VENTILATION SYSTEMS SUPPLY VENTS

B.Sc. MICROBIOLOGY SYLLABUS DDU GORAKHPUR UNIVERSITY, GORAKHPUR Industrial Microbiology D. D. U. Gorakhpur University, Gorakhpur B.Sc.

Specificity of Immunofluorescent Staining for Study

Available online at Evaluation of microbial content of some sunscreen creams in Iran s market

INTERNATIONAL STANDARDS ON FLUID PREPARATION FOR CONVECTIVE THERAPIES. Richard A. Ward, Ph.D.

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

PhEn-602 Notes # 4 J. Manfredi

Available online at

TOXIC MOLD IS NOT THE PROBLEM by: Michael D. Geyer and Kenneth V. La Conde

USP <797> and Environmental Sampling

Library Guide: Active Pharmaceutical

MICROBIAL GROWTH. Dr. Hala Al-Daghistani

Aspergillus terreus Thom a new pathogen that causes foliar blight of potato

Final text for addition to The International Pharmacopoeia

Limited Mold Sampling Investigation Report

Indoor air quality at selected wards at a South African government hospital. *N.J. Malebo 1 and K. Shale 2

Compounding Aseptic Isolators (CAI) James T Wagner

Transcription:

DESIGNING YOUR ENVIRONMENTAL MONITORING PROGRAM FOR MOLD Presented by Aaron Bisceglia

AGENDA Introduction What is an EM Program and why is it important to ensure product quality? What is Mold and why is it so critical to gear a portion of your EM program specifically for mold? Regulatory observations related to Mold and why the heightened focus on mold Setting acceptance criteria Setting appropriate controls to mitigate against mold Investigating Mold Excursions and Adverse trends Trending and data compilation Questions? References

INTRODUCTION 14 years experience in QC Microbiology Managed EM programs for past 9 years of career Have developed and revised EM programs at multiple companies Have been a front room presenter to FDA for EM programs at multiple companies Why I chose this topic

WHAT IS AN EM PROGRAM AND WHY IS IT CRITICAL FOR PRODUCT QUALITY? An EM program allows for detection of contamination and measures the effectiveness of your controls An effective EM program will often help detect contamination and allow for proactive contamination mitigation before contamination reaches product Regulatory agencies require environmental monitoring of the areas where product is manufactured

WHAT IS MOLD? Mold are multicellular filamentous fungi Mold develop hyphae which are tubular structures mold used to find and distribute food Hyphae grow and intertwine until they form a network of threads called a mycelium Morphology consists of powdery fluffy aerial growths above media Ubiquitous to all environments, however grow best in warm, damp, humid conditions. There are over 100,00 species with small percentage as known human pathogens Examples of common cleanroom Mold genuses are Aspergillus Cladisporium, Alternaria, and Penicillium

WHAT ARE MOLD SPORES? Mold produce spores small 1-50 µm (500 1000 could fit on a pin head), which are released into the air during reproduction Mold spores can survive harsh environmental conditions and are resistant to most disinfectants spores are numerous and spread easily through HEPA-filtered airflow patterns Mold colony can produce and release billions of spores daily.

WHAT ARE MYCOTOXINS? Some mold species can produce mycotoxins Mycotoxins are secondary metabolites produced by molds and other fungi Mycotoxins are present throughout mold colony, including the spores Mold produce mycotoxins as an evolutionary advantage to kill of other competing organisms or to weaken host defenses Three genera are responsible for the majority of the mycotoxins with which FDA is concerned: the Aspergillus Penicillium and Fusarium

WHAT ARE MYCOTOXINS Some mycotoxins such as aflatoxin b most potent natural carcinogen known Satratoxin from Stachybotrys chartarum black mold was thought to have been the active component in biological weapon Yellow Rain Most mycotoxins are stable compounds that are not destroyed during product processing or home cooking FDA recommends mycotoxin analysis methodology involving quantitative and qualitative analysis through HPLC or thin layer chromatography

WHAT ARE MYCOTOXINS? Mycotoxin Associated Mold Genera Effect on Human Body Aflatoxin Aspergillus carcinogen, immune suppression, primary target Liver Citrinin Penicillim Aspergillus nephrotoxin Fumonisin Fusarium carcinogen Ochratoxin Aspergillus, Penicillium nephrotoxin Patulin Penecillium immunological, neurological and gastrointestinal Trichothecenes Fusarium, Stachybotrys, Trichoderma, Trichothecium immunological, neurological and gastrointestinal

REGULATORY OBSERVATIONS RELATED TO MOLD AND CLEAN ROOMS Abundance of mold related excursions within aseptic processing areas without identifying appropriate corrective action. No data to support the appropriateness of the disinfectants used, inadequate or absence of disinfectant efficacy studies your firm s microbiology laboratory does not perform species identification on a routine basis of the yeast and molds detected in your production area Mold observed in cleanrooms Stains discoloration and appearance of clean rooms, Persistent mold problem not resolved There was no assurance that yeast and mold will grow at the Incubation temperature used to detect bacteria growth

RECALLS RELATED TO MOLD As per FDA data analysis 1998-2006, approximately one quarter of all product contaminations were related to fungi. Many Food related recalls In 1996, the FDA recalled an opthalmic solution because it was contaminated with Fusarium. New England Compounding contaminated steroid injections More than 60 people died, and 700 were infected contaminated with a fungus Exserohilum rostratum, Aspergillus fumigatus,and the common cleanroom mold Cladosporium rostratum, Aspergillus fumigatus (one patient).

GENERATE YEAST/MOLD SPECIFIC DATA Selective media: Rose Bengal w/ Chloramphenicol and Sabouraud Dextrose Agar Tryptic Soy Agar broad spectrum media will also recover mold, but must validate Mold prefer temperatures 20-25ºC Build SOPs to count specifically for yeast and mold Separation of mold data will allow for generation specific mold trends.

HOW TO SET MOLD SPECIFIC ACCEPTANCE CRITERIA? Perform statistical analysis using historical data, to set mold specific acceptance criteria Aseptic Facilities, ISO 7 areas really should not have any mold, so action level should be set low 1-2 CFUs. Utilize risk assessment to justify levels Don t set mold levels arbitrarily

SETTING APPROPRIATE CONTROLS Cleaning and disinfection program with risk assessment. Frequency, cleaning agent, cleaning sites (drains etc ) Proper traffic and material flow Cleaning of materials / Disinfectant efficacy study including sporicidal Gowning and Vendor qualification

SETTING APPROPRIATE CONTROLS Aseptic technique and behavior training Hygiene controls such as handwashing HVAC HEPA Filtration and facility design Contamination response plans Quality oversight!

INVESTIGATING MOLD EXCURSIONS Trending is key Personnel interviews Cross-functional walk-throughs of the affected area Look for water source damp areas drywall, refrigerators, condensation, recent leaks, areas of discoloration food source such as corrugated cardboard bags boxes paper markers Analyst / operator technique and training

INVESTIGATING MOLD EXCURSIONS HVAC returns and Dampers installed HEPA filters Were materials properly cleaned, was cleaning agent affective against mold spores Develop an overview map of the excursions Seasonal variation and year to year comparison

INVESTIGATING MOLD EXCURSIONS Map area activities with mold recovery Regulatory agencies expect facilities to make every effort to get to a root cause. If you cannot find a root cause the investigations should document review of above areas.

TRENDING AND DATA COMPILATION Build trending systems with specific components for mold to allow for mold specific trending Separate charts for yeast and mold Define Adverse Trend!

QUESTIONS?

REFERENCES Russell, A.D. (2003) Similarities and differences in the responses of microorganisms to biocides. J An-timicrob Chemother 52: 750-763. Microbial diversity in pharmaceutical product recalls and environments.jimenez L 1. www.cdc.gov FDA.gov: Bacteriological Analytical Manual Chapter 18 Yeasts, Molds and Mycotoxins Authors: Valerie Tournas, Michael E. Stack, Philip B. Mislivec, Herbert A. Koch and Ruth Bandler PDA tech report 13 USP <1116> FDA field manual DOCUMENT NO.: IV-07 VERSION NO.: 1.6 FINAL EFFECTIVE DATE: 04-27-04 REVISED: 02-14-13 Orientation and training Oxford Journals Volume 104, Issue 1Pp. 4-26 Stachybotrys chartarum, Trichothecene Mycotoxins, and Damp Building Related Illness: New Insights into a Public Health Enigma MycotoxinsJ. W. Bennett1,* and M. Klich2 Clin. Microbiol. Rev. July 2003 vol. 16 no. 3 497-516 1 July 2003 http://www.microbiologyonline.org.uk/about-microbiology/introducing-microbes/fungi